Free Weekly Vaccines Industry Newsletter Get the latest news about Research Breakthroughs, R&D Trends, and Vaccine Production sent straight to your Inbox. Join over 30,000 lab research professionals who subscribe to FierceVaccines for FREE! Click here to see a sample.
Getting the most PoC data in Phase I cancer studies
| Now Available On-demand
The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Watch today!
Forest Pleased with Delaware Court’s Decision on Icahn Litigation
NSF International Acquires Becker & Associates Consulting, Inc., a Leading Clinical, Regulatory and Scientific Consulting Firm Specializing in the FDA-Regulated Medical Devices, Pharmaceuticals and Biologics Industries
NSF International Acquires Becker & Associates Consulting, Inc., a Leading Clinical, Regulatory and Scientific Consulting Firm Specializing in the FDA-Regulated Medical Devices, Pharmaceuticals and Biologics Industries
The Gomez Law Firm Launches New Website Representing Victims Of Defective Stryker Hip Replacement Systems
NSF International Acquires Becker & Associates Consulting, Inc., a Leading Clinical, Regulatory and Scientific Consulting Firm Specializing in the FDA-Regulated Medical Devices, Pharmaceuticals and Biologics Industries
Latest Commentary